Accelerating Patient-Centered Research
The Addario Lung Cancer Medical Institute (ALCMI) and GO2 for Lung Cancer (GO2) are strategic partners that drive innovative, patient-centered research across the lung cancer care continuum. By combining GO2’s expertise and trusted patient relationships with ALCMI’s robust clinical research capabilities, we make it easier to recruit and enroll patients into our decentralized clinical trials. This unique partnership accelerates smarter, faster, and more impactful science, unmatched in the field of lung cancer research.
A Research Ecosystem
The ALCMI/GO2 partnership offers a unique model for accelerating discovery by combining:
GO2’s Strengths
- Deep relationships with patients to identify priority research questions based on unmet needs
- Expertise to facilitate research study design and implementation
- Centers of Excellence network comprises local community hospitals, clinics, and academic and VA medical centers across the U.S.
- Policy and awareness platforms to support research implementation
- Strong partnerships with private philanthropists
ALCMI’s Capabilities
- Clinical protocol design, IRB/regulatory support, and project management
- Centralized biobanking and biospecimen collection
- Access to a global network of academic and clinical investigators
- Infrastructure to launch and manage investigator-initiated studies
Together, we provide an end-to-end ecosystem where research can move seamlessly from concept to clinic, with patients involved throughout the process.
Let’s Accelerate What Matters
Whether you’re an early-career investigator or an established research leader, the ALCMI/GO2 partnership offers an infrastructure to scale your ideas and deepen their impact. We work with academic institutions, community clinics, biotech and pharma partners, and individual investigators.
If you're developing a concept or seeking collaboration, we want to hear from you.
